Prescription of QT-prolonging drugs in a cohort of about 5 million outpatients - Curtis, Lesley H; Østbye, Truls; Sendersky, Veronica; Hutchison, Steve; Allen LaPointe, Nancy M; Al-Khatib, Sana M; Usdin Yasuda, Sally; Dans, Peter E; Wright, Alan; Califf, Robert M; Woosley, Raymond L; Schulman, Kevin A (The American journal of medicine, 2003)
Keywords: Adult; Aged; Amitriptyline - adverse effects; Anti-Bacterial Agents - adverse effects; Anti-Infective Agents - adverse effects; Antidepressive Agents, Second-Generation - adverse effects; Antidepressive Agents, Tricyclic - adverse effects; Biological and medical sciences; Clarithromycin - adverse effects; Cohort Studies; Drug Prescriptions - statistics & numerical data; Drug Synergism; Drug toxicity and drugs side effects treatment; Erythromycin - adverse effects; Female; Fluoxetine - adverse effects; Heart Conduction System - drug effects; Humans; Male; Medical sciences; Middle Aged; Ofloxacin - adverse effects; Outpatients; Patients; Pharmacology. Drug treatments; Polypharmacy; Prescription drugs; Torsades de Pointes - chemically induced; Toxicity: cardiovascular system; United States; United States; Heart; Human; QT interval; Wave burst; Arrhythmia; Toxicity; Prolonged QT interval; Cardiovascular disease; Conduction disorder; Excitability disorder; Antibiotic; Heart block; Heart disease; Cohort study; Antidepressant agent; Antibacterial agent